BriaCell Therapeutics (TSE:BCT) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
BriaCell Therapeutics has announced its plans to sell common shares and warrants in an underwritten public offering. The company aims to use the proceeds for working capital, corporate purposes, and advancing its business goals. The offering’s completion depends on market conditions and there is no guarantee it will be finalized.
For further insights into TSE:BCT stock, check out TipRanks’ Stock Analysis page.
